A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)
Clinical trial NCT00788593 · COMPLETED
Trial details
- NCT number
- NCT00788593
- Sponsor
- Forest Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-03-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.